Effect of Blood Collection Time on Measured Δ9-Tetrahydrocannabinol Concentrations: Implications for Driving Interpretation and Drug Policy. (6th January 2020)
- Record Type:
- Journal Article
- Title:
- Effect of Blood Collection Time on Measured Δ9-Tetrahydrocannabinol Concentrations: Implications for Driving Interpretation and Drug Policy. (6th January 2020)
- Main Title:
- Effect of Blood Collection Time on Measured Δ9-Tetrahydrocannabinol Concentrations: Implications for Driving Interpretation and Drug Policy
- Authors:
- Hartman, Rebecca L
Brown, Timothy L
Milavetz, Gary
Spurgin, Andrew
Gorelick, David A
Gaffney, Gary R
Huestis, Marilyn A - Abstract:
- Abstract: BACKGROUND: In driving-under-the-influence cases, blood typically is collected approximately 1.5–4 h after an incident, with unknown last intake time. This complicates blood Δ 9 -tetrahydrocannabinol (THC) interpretation, owing to rapidly decreasing concentrations immediately after inhalation. We evaluated how decreases in blood THC concentration before collection may affect interpretation of toxicological results. METHODS: Adult cannabis smokers (≥1×/3 months, ≤3 days/week) drank placebo or low-dose alcohol (approximately 0.065% peak breath alcohol concentration) 10 min before inhaling 500 mg placebo, 2.9%, or 6.7% vaporized THC (within-individuals), then took simulated drives 0.5–1.3 h postdose. Blood THC concentrations were determined before and up to 8.3 h postdose (limit of quantification 1 μg/L). RESULTS: In 18 participants, observed Cmax (at 0.17 h) for active (2.9 or 6.7% THC) cannabis were [median (range)] 38.2 μg/L (11.4–137) without alcohol and 47.9 μg/L (13.0–210) with alcohol. THC Cmax concentration decreased 73.5% (3.3%–89.5%) without alcohol and 75.1% (11.5%–85.4%) with alcohol in the first half-hour after active cannabis and 90.3% (76.1%–100%) and 91.3% (53.8%–97.0%), respectively, by 1.4 h postdose. When residual THC (from previous self-administration) was present, concentrations rapidly decreased to preinhalation baselines and fluctuated around them. During-drive THC concentrations previously associated with impairment (≥8.2 μg/L) decreased toAbstract: BACKGROUND: In driving-under-the-influence cases, blood typically is collected approximately 1.5–4 h after an incident, with unknown last intake time. This complicates blood Δ 9 -tetrahydrocannabinol (THC) interpretation, owing to rapidly decreasing concentrations immediately after inhalation. We evaluated how decreases in blood THC concentration before collection may affect interpretation of toxicological results. METHODS: Adult cannabis smokers (≥1×/3 months, ≤3 days/week) drank placebo or low-dose alcohol (approximately 0.065% peak breath alcohol concentration) 10 min before inhaling 500 mg placebo, 2.9%, or 6.7% vaporized THC (within-individuals), then took simulated drives 0.5–1.3 h postdose. Blood THC concentrations were determined before and up to 8.3 h postdose (limit of quantification 1 μg/L). RESULTS: In 18 participants, observed Cmax (at 0.17 h) for active (2.9 or 6.7% THC) cannabis were [median (range)] 38.2 μg/L (11.4–137) without alcohol and 47.9 μg/L (13.0–210) with alcohol. THC Cmax concentration decreased 73.5% (3.3%–89.5%) without alcohol and 75.1% (11.5%–85.4%) with alcohol in the first half-hour after active cannabis and 90.3% (76.1%–100%) and 91.3% (53.8%–97.0%), respectively, by 1.4 h postdose. When residual THC (from previous self-administration) was present, concentrations rapidly decreased to preinhalation baselines and fluctuated around them. During-drive THC concentrations previously associated with impairment (≥8.2 μg/L) decreased to median <5 μg/L by 3.3 h postdose and <2 μg/L by 4.8 h postdose; only 1 participant had THC ≥5 μg/L after 3.3 h. CONCLUSIONS: Forensic blood THC concentrations may be lower than common per se cutoffs despite greatly exceeding them while driving. Concentrations during driving cannot be back-extrapolated because of unknown time after intake and interindividual variability in rates of decrease. … (more)
- Is Part Of:
- Clinical chemistry. Volume 62:Number 2(2016)
- Journal:
- Clinical chemistry
- Issue:
- Volume 62:Number 2(2016)
- Issue Display:
- Volume 62, Issue 2 (2016)
- Year:
- 2016
- Volume:
- 62
- Issue:
- 2
- Issue Sort Value:
- 2016-0062-0002-0000
- Page Start:
- 367
- Page End:
- 377
- Publication Date:
- 2020-01-06
- Subjects:
- Clinical chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Biochimie -- Périodiques
Diagnostics biologiques -- Périodiques
Biochemistry
Clinical chemistry
Pharmaceutical chemistry
Biochemistry
Laboratory Techniques and Procedures
Klinische chemie
Periodicals
616.075605 - Journal URLs:
- http://www.oxfordjournals.org/ ↗
https://academic.oup.com/clinchem ↗
http://catalog.hathitrust.org/api/volumes/oclc/1554929.html ↗
http://www.clinchem.org/ ↗ - DOI:
- 10.1373/clinchem.2015.248492 ↗
- Languages:
- English
- ISSNs:
- 0009-9147
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17850.xml